Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?

Antiinflamm Antiallergy Agents Med Chem. 2020;19(2):85-87. doi: 10.2174/1871523019999200228100917.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives*
  • Adenosine Monophosphate / pharmacology
  • Alanine / analogs & derivatives*
  • Alanine / pharmacology
  • Angiotensin-Converting Enzyme 2
  • Antiviral Agents / pharmacology
  • Betacoronavirus* / drug effects
  • Betacoronavirus* / pathogenicity
  • Betacoronavirus* / physiology
  • COVID-19
  • Chloroquine / pharmacology*
  • Communicable Disease Control / methods
  • Coronavirus Infections* / drug therapy
  • Coronavirus Infections* / epidemiology
  • Coronavirus Infections* / transmission
  • Drug Discovery / methods*
  • Drug Repositioning / methods*
  • Humans
  • Pandemics*
  • Peptidyl-Dipeptidase A / metabolism
  • Pneumonia, Viral* / drug therapy
  • Pneumonia, Viral* / epidemiology
  • Pneumonia, Viral* / transmission
  • SARS-CoV-2
  • Virus Internalization / drug effects

Substances

  • Antiviral Agents
  • remdesivir
  • Adenosine Monophosphate
  • Chloroquine
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2
  • Alanine